Does neuroprotection improve stroke outcome?
- 1 May 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 351 (9114), 1447-1448
- https://doi.org/10.1016/s0140-6736(05)78865-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Multinational Randomised Controlled Trial of Lubeluzole in Acute Ischaemic StrokeCerebrovascular Diseases, 1998
- Stroke Units Versus General Medical Wards, I: Twelve- and Eighteen-Month SurvivalStroke, 1998
- Lubeluzole Treatment of Acute Ischemic StrokeStroke, 1997
- Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up studyBMJ, 1997
- Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after strokeBMJ, 1997
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeNew England Journal of Medicine, 1996
- Lubeluzole in Acute Ischemic StrokeStroke, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic strokeThe Lancet, 1995
- A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Intravenous Magnesium Sulfate in Acute StrokeStroke, 1995